The HM-SCREEN01 study also showed that AML with RUNX1-RUNX1T1 accounted for a very high proportion of patients with R/R AML with KIT mutations, but this point needs to be confirmed in the future by increasing the study population. This evidence concerns the gene RUNX1T1 and acute myeloid leukemia.